It is with delight and excitement to announce Yoshiyuki Fukase, Vice President of Medicinal Chemistry and CMC, staring in January 2024. Yoshi brought nearly 20 years of experience from Ferring, Takeda, and the MSKCC/Rockefeller Univ./Weill Cornell Tri-Institutional Therapeutics Discovery Institute. He has made breakthrough discoveries and delivered multiple clinical compounds as leader of projects across multiple organizations. Yoshi is an author or inventor of over 40 publications and patents. Welcome to Maipl Therapeutics!
Congratulations
Director Aragen Life Sciences Ltd, Postdoc Fellow from UT Knoxville, TN, US, Texas Tech University, Texas Pan American, PhD from NCL Pune , Scientific Guest from Freie University of Berlin Germany
9moCongratulations Yoshi for new role and responsibility.